市場調查報告書
商品編碼
1235929
全球軟組織修復市場:到 2028 年的預測——按類型(組織貼片、組織固定產品、腹腔鏡器械、其他類型)、應用、最終用戶、地區Soft Tissue Repair Market Forecasts to 2028 - Global Analysis By Type (Tissue Patch, Tissue Fixation Products, Laparoscopic Instrument and Other Types), Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球軟組織修復市場預計將在 2022 年達到 136 億美元,到 2028 年達到 201 億美元,預測期內的複合年增長率為 6.7%,有望實現增長。
軟組織損傷會損傷肌肉、韌帶和肌腱,引起炎症和疼痛。 軟組織修復是通過用健康組織替換受傷或損壞的組織來完成的。 目前的治療通常依賴於成功率低的手術。 因此,需要創新和先進的治療方法,例如微創手術和快速癒合產品。
在美國,每年約有 350 萬兒童和青少年遭受運動損傷,預計這將推動軟組織修復市場的增長。 根據美國運動醫學雜誌,ACL 損傷的發生率為每年每 100,000 人中有 68.6 人。
老年人口的增長表明對骨科手術的需求不斷增長。 跌倒和事故造成傷害的頻率越來越高,預計將導致全球創傷手術數量的增加。 因此,日益老齡化的人口正在推動市場的增長。
產品進入臨床試驗階段所需的成本和時間非常高,批准的可能性非常低。 軟組織修復產品屬於 3 類產品,必須嚴格遵守監管指南。 因此,即使進行大量投資,也存在很高的失敗風險,阻礙了市場的擴張。
人們越來越意識到運動和身體活動有益於您的健康。 正因為如此,這項運動越來越受到年輕人的歡迎。 隨著參與運動的增加,與運動相關的軟組織損傷正在增加,推動了市場的增長。
我們產品的價格競爭非常激烈。 許多軟組織修復產品的高成本限制了它們的採用。 目前的商業產品由複雜的重組組成,保質期很短。 因此,這些阻礙了市場的增長。
COVID-19 大流行對軟組織修復市場產生了重大影響。 危機和由此導致的停工對各行各業的運營和經濟產生了嚴重影響。 由於醫療保健服務中斷的增加,尤其是對傷口患者的護理,以及傷口護理提供方式的重大變化,市場也感受到了爆發的熱度。 然而,預計在大流行期間,不僅對受影響患者的皮膚而且對因壓力造成的軟組織損傷的擔憂也會增加。
由於軟組織修復手術的增加,預計疝氣修復領域將實現有利可圖的增長。 由於許多其他因素的影響,例如對改進網格的需求不斷增長、機器人手術的使用增加以及對改進網格的需求,正在推動這一領域的增長。
由於選擇診所接受優質醫療服務的患者激增,預計診所部分在預測期內將以最快的複合年增長率增長。 此外,由於許多診所強調需要提供具有成本效益、高質量和個性化的服務,因此產品採用率預計會增加。
由於對醫療技術的需求不斷增加、健康意識不斷增強以及與骨科疾病患病率上升相關的老齡化率不斷上升,預計亞太地區在預測期內將佔據最大的市場份額。 此外,本地醫療設備製造商的滲透正在取得進展,為該地區的市場創造了重要的增長機會。
由於對軟組織修復產品的需求增加,預計北美在預測期內的複合年增長率最高。 不斷上漲的醫療保健成本和對醫療保健基礎設施的投資使得昂貴的骨科軟組織修復手術變得更加負擔得起,從而推動了該地區的增長。
軟組織修復市場的主要參與者是: Allergan Plc.、Smith & Nephew PLC、Stryker Corporation、Medtronic Plc.、Zimmer Biomet Holdings, Inc.、Integra LifeScience Corporation、Isto Biologics、Organogenesis Inc.、Depuy Synthes、Wright Medical Group, Inc、Lifenet Health、 Inc.., American Medical Systems Inc., CryoLife, Inc., Arthrex, Inc., S. Stem Cell, Inc., R. Bard, Inc., LifeCell International Pvt. Ltd., Johnson & Johnson Private Limited, Boston Scientific Corporation 和 Athersys. Inc.
2021 年 1 月,Smith & Nephew 將收購 Integra Lifesciences Holdings Corporation 的高度骨科業務。
2019 年 12 月,美敦力 (Medtronic) 的 Dextile Anatomical Mesh 獲得了美國 FDA 的批准。 這種疝氣修復網可廣泛覆蓋肌果膠開口,最大限度地降低復發風險並在通過套管針後保持形狀。
購買此報告的客戶將免費獲得以下定制之一。
According to Stratistics MRC, the Global Soft Tissue Repair Market is accounted for $13.6 billion in 2022 and is expected to reach $20.1 billion by 2028 growing at a CAGR of 6.7% during the forecast period. Soft tissues injuries involve harm to the muscles, ligaments and tendons that will result in the inflammation as well as pain. Soft tissue repair is accomplished by replacing injured or damaged tissues with healthy tissues. The current treatment options are heavily reliant on surgical methods with a low success rate. As a result, prevalent, innovatively advanced options such as minimally invasive processes and rapid healing products are critical.
According to estimates, approximately 3.5 million sports injuries occur in children and teenagers in the United States each year which is further anticipated to propel the growth of the soft tissue repair market. According to the American Journal of Sports Medicine, the incidence of ACL injury is 68.6/100,000 individuals per year.
The growing geriatric population indicates that need for orthopaedic procedures would increase. The rising frequency of trauma injuries and injuries from falls and accidents is predicted to increase the number of trauma operations done globally. Hence, growing geriatric population is propelling the market growth.
The cost and time needed for a product to enter the clinical trial stage are very high, with very low prospects of approval. Soft tissue repair products are classified as class 3 products, which necessitate stringent adherence to regulatory guidelines. Therefore, despite significant investments, there is a high risk of failure, which is hindering the market expanding.
There is a growing awareness of the health advantages of sports and physical activity. This has increased the popularity of sports among the youth. With the increasing sports participation, the number of sport related soft tissue injuries is increased, which is propelling the growth of the market.
The products are extremely competitive in terms of pricing. The adoption of many soft tissue repair products is limited due to their high cost. The products currently available on the market are made of complicated reconstitutions with a poor shelf life. Hence, these are the prospects hampering the market growth.
The pandemic of COVID-19 has had a huge impact on the soft tissue repair market. The crisis and the ensuing lockdowns had severe operational and economic consequences across the industrial spectrum. The market also felt the heat of the outbreak as a result of rising disruptions in health care services, particularly the care of patients with wounds, which resulted in significant shifts in the delivery of wound care. However, the concerns over pressure-induced skin as well as soft tissue injuries in the affected patients is expected to rise in the pandemic.
The hernia repair segment is estimated to have a lucrative growth, due to increase in soft tissue repair surgeries. It is expanding as a result of numerous additional factors, including increased need for improved mesh, increased usage of robotic operations, and the desire for improved mesh, which is boosting the segment's growth.
The clinics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the surging number of patient's preference for clinics for quality care. Furthermore, the majority of clinics are emphasising the need of providing cost-effective, high-quality, and individualised services, which is anticipated to increase product adoption.
Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing demand for medical technology, growing health awareness, and growing aging population coupled with the rising prevalence of orthopedic diseases. Higher penetration of local manufacturers of medical devices is providing significant growth opportunities for the market in the region.
North America is projected to have the highest CAGR over the forecast period, owing to rise in the demand for soft tissue repair products. Rising healthcare expenditure and investments in healthcare infrastructure as an increase in healthcare spending can help make expensive orthopedic soft tissue repair surgeries more affordable which is boosting the growth of the region.
Some of the key players profiled in the Soft Tissue Repair Market include: Allergan Plc., Smith & Nephew PLC, Stryker Corporation, Medtronic Plc., Zimmer Biomet Holdings, Inc., Integra LifeScience Corporation, Isto Biologics, Organogenesis Inc., Depuy Synthes, Wright Medical Group, Inc., Lifenet Health, Inc., American Medical Systems Inc., CryoLife, Inc., Arthrex, Inc., S. Stem Cell, Inc., R. Bard, Inc., LifeCell International Pvt. Ltd., Johnson & Johnson Private Limited, Boston Scientific Corporation and Athersys Inc.
In January 2021, Smith & Nephew acquires the extremely Orthopaedics business of Integra Lifesciences Holdings Corporation.
In December 2019, Medtronic received U.S FDA approval for its Dextile Anatomical Mesh. This hernia repair mesh provides wide coverage of the myopectineal orifice to minimize the risk of recurrence and maintain shape after trocar passage.
All the customers of this report will be entitled to receive one of the following free customization options:
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.